Corey J. Langer
0000-0002-8483-6811
Publication & Citation Trends
Publications
0 total
Carboplatin plus pemetrexed versus pemetrexed alone in advanced thymoma and thymic carcinoma: a retrospective cohort study
Cited by 0
Semantic Scholar
The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing
Cited by 0
Semantic Scholar
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy.
Cited by 1
Semantic Scholar
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis. OA
Cited by 3
Semantic Scholar
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy OA
Cited by 1
Semantic Scholar
Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients OA
Cited by 2
Semantic Scholar
Electronic Medical Record–Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non–Small Cell Lung Cancer: Results From a Prospective Clinical Trial
Cited by 2
Semantic Scholar
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
Cited by 152
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(512)
Lung Cancer Diagnosis and Treatment
(270)
Lung Cancer Research Studies
(229)
Cancer Immunotherapy and Biomarkers
(116)
Cancer Genomics and Diagnostics
(80)
Affiliations
Rutgers, The State University of New Jersey
American College of Radiology
University of Southern California
Hershey (United States)
University of Iowa